Previous close | 0.00 |
Open | 169.00 |
Bid | 149.09 x 40700 |
Ask | 160.66 x 36900 |
Day's range | 166.00 - 169.00 |
52-week range | 118.16 - 175.00 |
Volume | |
Avg. volume | 2,045 |
Market cap | 246.024B |
Beta (5Y monthly) | 0.17 |
PE ratio (TTM) | 37.05 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.98 (1.95%) |
Ex-dividend date | 08 Aug 2024 |
1y target est | N/A |
FDA approves Sanofi's Dupixent for COPD. Eli Lilly is set to invest $4.5 billion to build a new manufacturing and research site in Indiana.
ABBV lowers adjusted earnings guidance for 2024 from $10.71-$10.91 per share to $10.67-$10.87 to account for acquisition costs.
Multi-asset funds have been put forward as one way to manage the impact of a mooted capital gains tax hike on investment portfolios.